The Mumbai-headquartered company said the acquisition, to be carried out through its wholly owned subsidiary Hexaware Technologies UK Ltd, ...

Adcounty Media India launched its Rs 50.69 crore IPO today, featuring a fresh offer of 59.63 lakh equity shares priced between Rs 80 and Rs...

PNC Infratech gains in-principle NHAI approval to transfer a 100% stake in two subsidiaries managing Bundelkhand and Khajuraho road project...

The board has established a fundraising committee and granted them the authority to manage all aspects of raising funds, such as deciding t...

AEL has rated loans of ₹13,900 crore. They comprise fund-based and non-fund-based loans, as per a Care Rating report released in mid-Octobe...

The telecom operator is selling commercial papers (CPs) with maturities of up to 12 months, the people said. SBI Mutual Fund is said to hav...

Panasonic is joining the high-growth electric vehicles market, with plans to invest nearly $4.9 billion in automotive batteries, supply cha...

Adani Transmission will acquire 13,135,000 (100 per cent) equity shares of Rs 10 each of MUL.

Out of Rs 65 crore that fell due, the company repaid only Rs 15 crore to investors of CPs.

This will be in addition to undertaking eligible transactions with Scheduled Commercial Banks and Primary Dealers.

On May 15, the National Company Law Tribunal approved Tata Steel’s bid for Bhushan Steel Limited (BSL), paving the way for the acquisition ...

Entering debt market for the first time, it has managed to borrow at a rate even lower than what ONGC earns on its deposits. World's larges...

Sun Pharmaceutical Industries has acquired 100% ownership in a US-based Chattem Chemicals (Chattem) from Elcat.

DRL is looking at acquisitions in areas such as branded formulations, generics and custom pharma services in US and other mkts. Night club ...

Hyderabad-based Dr Reddy’s Labs announced it will acquire the UK business of Dowpharma Small Molecules, a unit of the $54-billion Dow Chemi...

Dr Reddy’s Laboratories is in the race with three other Indian drug majors to acquire US-based generic drug maker Par Pharma.

With more banks refusing to lend them, fin cos - have found a new source of finance: the mutual fund.